Letter to Dreesen et al. on their article "Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients With Crohn's Disease"-A comprehensive review of infliximab population pharmacokinetic modelling publications

Br J Clin Pharmacol. 2021 Mar;87(3):1594-1595. doi: 10.1111/bcp.14554. Epub 2020 Dec 2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Crohn Disease* / drug therapy
  • Feces
  • Humans
  • Infliximab
  • Leukocyte L1 Antigen Complex*

Substances

  • Antibodies, Monoclonal
  • Leukocyte L1 Antigen Complex
  • Infliximab